PPARg shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc.

Product Specs
ItemPPARg shRNA Plasmid (h)
CompanySanta Cruz Biotechnology, Inc.
Price $592.00Supplier Page View Company Product Page
Catalog Numbersc-29455-SH
Quantity20 µg
RNA TypeshRNA Clones
Vector Type (Standardized)Lentiviral
NCBI Gene AliasesCIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARG5, PPARgamma
NCBI Full Gene Nameperoxisome proliferator activated receptor gamma
Specieshuman
TypeshRNA Plasmid

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) The Activation of PPARγ by (2Z,4E,6E)-2-methoxyocta-2,4,6-trienoic Acid Counteracts the Epithelial-Mesenchymal Transition Process in Skin CarcinogenesisCellsMarch 24, 2023Flori E, Mosca S, Cardinali G, Briganti S, Ottaviani M, Kovacs D, Manni I, Truglio M, Mastrofrancesco A, Zaccarini M, et al.

(2) Diverse Effects of Cilostazol on Proprotein Convertase Subtilisin/Kexin Type 9 between Obesity and Non-ObesityInternational journal of molecular sciencesAugust 29, 2022Chen PW, Tseng SY, Chang HY, Lee CH, Chao TH.

(3) Genetic and pharmacologic suppression of PPARγ enhances NELL-1-stimulated bone regenerationBiomaterialsAugust 1, 2022Justine Tanjaya, Pin Ha, Yulong Zhang, Chenchao Wang, Yash Shah, Emily Berthiaume, Hsin Chuan Pan, Jiayu Shi, Jinny Kwak, Benjamin Wu, et al.lentiviral vectors were generated by co-transfecting 293T cells with the PPARγ-shRNA plasmid vector (SC-29455-SH; Santa Cruz Biotechnology) or the FG12 vector (14884; Addgene) with the helper plasmids pCMV-dR8.2-vprX

(4) Qihuang Zhuyu Formula Attenuates Atherosclerosis via Targeting PPARγ to Regulate Cholesterol Efflux and Endothelial Cell InflammationOxidative medicine and cellular longevityJanuary 1, 2022Wang M, Xiang Q, Sun W, Zhang H, Shi R, Guo J, Tong H, Fan M, Ding Y, Shi H, et al.

(5) PPARγ attenuates hepatic inflammation and oxidative stress of non‑alcoholic steatohepatitis via modulating the miR‑21‑5p/SFRP5 pathwayMolecular medicine reportsNovember 1, 2021Zhang X, Deng F, Zhang Y, Zhang X, Chen J, Jiang Y.

(6) Tectorigenin alleviates intrahepatic cholestasis by inhibiting hepatic inflammation and bile accumulation via activation of PPARγBritish journal of pharmacologyJune 1, 2021Xiang J, Yang G, Ma C, Wei L, Wu H, Zhang W, Tao X, Jiang L, Liang Z, Kang L, et al.

(7) Anti-influenza A Virus Effects and Mechanisms of Emodin and Its Analogs via Regulating PPARα/γ-AMPK-SIRT1 Pathway and Fatty Acid MetabolismBioMed research internationalJanuary 1, 2021Bei Y, Tia B, Li Y, Guo Y, Deng S, Huang R, Zeng H, Li R, Wang GF, Dai J.

(8) CB13, a novel PPARγ ligand, overcomes radio-resistance via ROS generation and ER stress in human non-small cell lung cancerCell death & diseaseOctober 13, 2020Kim TW, Hong DW, Hong SH.

(9) A novel PPARɣ ligand, PPZ023, overcomes radioresistance via ER stress and cell death in human non-small-cell lung cancer cellsExperimental & molecular medicineOctober 1, 2020Kim TW, Hong DW, Kang CM, Hong SH.

(10) Physcion 8-O-β-Glucopyranoside Exerts Anti-Tumor Activity Against Non-Small Cell Lung Cancer by Targeting PPARγAnatomical record (Hoboken, N.J. : 2007)May 1, 2019Du Y, Lv Z, Sun D, Li Y, Sun L, Zhou J.

(11) Peroxisome Proliferator-Activated Receptor-γ Knockdown Impairs Bone Morphogenetic Protein-2-Induced Critical-Size Bone Defect RepairThe American journal of pathologyMarch 1, 2019Wang C, Tanjaya J, Shen J, Lee S, Bisht B, Pan HC, Pang S, Zhang Y, Berthiaume EA, Chen E, et al.

(12) Curcumin inhibits the TGF-β1-dependent differentiation of lung fibroblasts via PPARγ-driven upregulation of cathepsins B and LScientific reportsJanuary 24, 2019Saidi A, Kasabova M, Vanderlynden L, Wartenberg M, Kara-Ali GH, Marc D, Lecaille F, Lalmanach G.

(13) Alkyl-glycerophosphate-mediated C-C motif chemokine 2 secretion induces oxidative stress via increased PPARγ activation in human umbilical vein endothelial cellsBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapieOctober 1, 2018Tsukahara T, Yamagishi S, Matsuda Y, Haniu H.

(14) Hispidulin inhibits hepatocellular carcinoma growth and metastasis through AMPK and ERK signaling mediated activation of PPARγBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapieJuly 1, 2018Han M, Gao H, Ju P, Gao MQ, Yuan YP, Chen XH, Liu KL, Han YT, Han ZW.

(15) Regulation of the metabolism of apolipoprotein M and sphingosine 1-phosphate by hepatic PPARγ activityThe Biochemical journalJune 21, 2018Kurano M, Ikeda H, Iso-O N, Hara M, Tsukamoto K, Yatomi Y.

(16) Insulin downregulates C3 gene expression in human HepG2 cells through activation of PPARγEuropean journal of cell biologyApril 1, 2018Shavva VS, Bogomolova AM, Efremov AM, Trofimov AN, Nikitin AA, Babina AV, Nekrasova EV, Dizhe EB, Oleinikova GN, Missyul BV, et al.

(17) Glycyrrhiza uralensis and Semilicoisoflavone B Reduce Aβ Secretion by Increasing PPARγ Expression and Inhibiting STAT3 Phosphorylation to Inhibit BACE1 ExpressionMolecular nutrition & food researchMarch 1, 2018Gu MY, Chun YS, Zhao D, Ryu SY, Yang HO.

(18) Silencing carboxylesterase 1 in human THP-1 macrophages perturbs genes regulated by PPARγ/RXR and RAR/RXR: down-regulation of CYP27A1-LXRα signalingThe Biochemical journalFebruary 9, 2018Mangum LC, Hou X, Borazjani A, Lee JH, Ross MK, Crow JA.

(19) Anticancer properties of 4-thiazolidinone derivatives depend on peroxisome proliferator-activated receptor gamma (PPARγ)European journal of medicinal chemistryDecember 1, 2017Szychowski KA, Leja ML, Kaminskyy DV, Kryshchyshyn AP, Binduga UE, Pinyazhko OR, Lesyk RB, Tobiasz J, Gmiński J.

(20) Expression of CYP4V2 in human THP1 macrophages and its transcriptional regulation by peroxisome proliferator-activated receptor gammaToxicology and applied pharmacologySeptember 1, 2017Yi M, Shin JG, Lee SJ.